1. Crizotinib in refractory ALK‐positive diffuse large B‐cell lymphoma: a case report with a short‐term response. (10th January 2014) Authors: Wass, Maxi; Behlendorf, Timo; Schädlich, Bärbel; Mottok, Anja; Rosenwald, Andreas; Schmoll, Hans‐Joachim; Jordan, Karin Journal: European journal of haematology Issue: Volume 92:Number 3(2014:Mar.) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non‐interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials. (15th November 2021) Authors: Dechow, Tobias; Aldaoud, Ali; Behlendorf, Timo; Knauf, Wolfgang; Eschenburg, Henning; Groschek, Matthias; Hansen, Richard; Söling, Ulrike; Grebhardt, Sina; Siebenbach, Hans Ulrich; Vannier, Corinne; Potthoff, Karin Journal: European journal of haematology Issue: Volume 108:Number 2(2022) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗